Total Non-Calcified Plaque Volume Test

Most heart attacks happen when a soft, fatty plaque inside an artery wall cracks open and triggers a clot. Not when an artery is slowly squeezed shut. The plaque that causes the cracking is rarely calcified, which means a standard calcium score can read zero while you still carry meaningful risk.

Total non-calcified plaque volume (often abbreviated NCPV) measures exactly that soft, dangerous plaque from a coronary CT angiogram, a heart-specific CT scan with contrast dye. The number tells you how much vulnerable plaque is sitting in your arteries right now, and tracking it over time tells you whether your prevention plan is actually working.

What This Number Actually Measures

Coronary CT angiography (CCTA) takes detailed images of your heart arteries and uses tissue density to sort plaque into categories. Hard, calcified plaque shows up bright. Softer plaque shows up dimmer, and the very dimmest material, called low-attenuation plaque, is the lipid-rich, inflammation-prone tissue most likely to rupture. Non-calcified plaque volume sums all the softer material across your coronary tree.

This makes it a direct anatomic measure of soft atherosclerotic burden, not a surrogate. A blood test like LDL cholesterol (the so-called bad cholesterol) tells you what is flowing through your arteries. Non-calcified plaque volume tells you what has already accumulated in the walls.

Heart Attack Risk

Across multiple large studies of people with chest pain or suspected coronary disease, higher non-calcified plaque volume independently predicts heart attacks and cardiac death, beyond traditional risk scores, calcium scores, and even artery narrowing on the same scan. Low-attenuation soft plaque is the standout signal.

In the SCOT-HEART trial of stable chest pain patients, low-attenuation non-calcified plaque was a strong predictor of future heart attack, beyond classical risk factors and calcium scoring. A low-attenuation plaque burden above roughly 4 percent was associated with about five times the risk of myocardial infarction (a heart attack) over nearly five years of follow-up compared with lower burden. In another long-term study tracking cardiac death, higher non-calcified plaque volume identified higher-risk individuals.

What this means for you: if your coronary CT shows substantial soft plaque, your near-term risk of a heart attack is materially elevated, and aggressive lipid lowering becomes a higher-priority decision rather than an optional one.

Risk in Women and Younger Adults

Women tend to have less total plaque than men at any given age, but their risk rises at lower plaque burdens. In the PROMISE trial of symptomatic outpatients, high-risk plaque features predicted major adverse cardiovascular events (the combined risk of heart attack, stroke, and cardiac death), particularly in women and younger adults. In the CONFIRM2 registry, each unit increase in non-calcified plaque carried higher relative risk in women than in men.

Younger people present a different pattern. Under age 50, almost all coronary plaque is non-calcified, because calcium has not yet had time to form. This is precisely the population where a calcium score of zero gives the most false reassurance. If you are under 55 and have a family history or genetic risk factor, the soft-plaque measurement is the one that will detect early disease.

Ischemia and Functional Significance

Soft plaque does not just predict events. It also predicts whether a given lesion is actually choking off blood flow. In studies pairing CCTA with invasive flow measurements, higher non-calcified and low-attenuation plaque volumes have been linked with functionally significant blockages, often better than visual stenosis assessment alone. A meta-analysis of CCTA studies confirmed that plaque burden and high-risk features improve the ability to discriminate ischemia (poor blood flow) beyond looking at narrowing alone.

When the Calcium Score Reads Zero

Roughly 1 in 10 asymptomatic adults with a calcium score of zero still carry detectable non-calcified plaque on coronary CT angiography. In symptomatic patients with zero calcium, the presence of soft plaque continues to predict adverse cardiac events. The point is not that calcium scoring is useless. The point is that for someone actively managing their cardiovascular risk, a zero calcium score does not close the case, especially under age 55 or in the setting of strong family history.

Reference Ranges

There is no universally standardized clinical cutpoint for non-calcified plaque volume. The values below come from large research cohorts using artificial intelligence quantification of coronary CT angiography. Your scan center may use different software, thresholds, or reporting units. Compare your results within the same imaging center and protocol over time rather than treating any single number as absolute.

Source: research cohorts including PROMISE and SCOT-HEART. Exact thresholds vary across studies and software. Compare your results within the same lab and software over time for the most meaningful trend.

Why a Single Reading Is Not Enough

Coronary plaque does not change quickly. What you actually want to know is the direction your number is moving and how fast. Is plaque accumulating, holding steady, or regressing? A single snapshot tells you where you stand. A second scan tells you whether your interventions are working.

Repeat imaging is most informative on a one to three year cycle. Statin therapy, for example, typically converts soft plaque into more stable calcified plaque over a 12 to 24 month window. If you are starting a new lipid-lowering regimen or making major lifestyle changes, a follow-up scan around two years out gives the clearest picture of impact. For someone already on therapy, scanning every two to three years is reasonable.

What to Do If Your Number Is High

An elevated non-calcified plaque volume is a call to act, not a diagnosis to fear. The most useful next steps are not more imaging right away but a tighter look at the drivers.

• Drill into the lipid panel: get apolipoprotein B (ApoB, a count of artery-damaging particles) and lipoprotein(a) (Lp(a), a genetic risk factor that standard cholesterol panels miss).
• Check inflammation: high-sensitivity C-reactive protein (hs-CRP) reveals whether systemic inflammation is fueling plaque growth.
• Look at glucose and insulin: HbA1c (a three-month blood sugar average) and fasting insulin help identify metabolic drivers.
• Consult a preventive cardiologist or lipidologist: someone who treats coronary disease aggressively in primary prevention can match therapy intensity to your actual plaque burden.

The combination of high non-calcified plaque volume plus elevated ApoB or Lp(a) usually warrants aggressive lipid lowering, often well below the LDL targets used for people without imaged plaque.

When Results Can Be Misleading

Non-calcified plaque volume is more technically dependent than a blood test. The number on your report can shift meaningfully based on factors that have nothing to do with your actual biology.

• Scanner and software differences: repeat scans on the same machine show modest variability, and different scanner vendors or software packages can push that higher. Compare scans done on the same equipment whenever possible.
• Reconstruction settings: sharper image kernels and different energy levels on newer photon-counting CT scanners can change measured soft plaque volume substantially. Ask your imaging center to use consistent protocols across scans.
• Image quality: high heart rate, irregular rhythm, breathing artifacts, or obesity can blur the borders the software needs to define plaque, lowering measurement accuracy.
• Reader and AI variability: agreement between expert readers is good for total and calcified plaque but weaker for the lowest-density soft plaque. Two analyses of the same scan can produce different numbers.

Because of this technical noise, small year-over-year changes may not represent real biological change. Trends become trustworthy when they are large, sustained across multiple scans, and measured on consistent equipment.